EcoDrugPlus

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSJJAG00000019097
Gene Symbol: PTGS1
3 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSJJAG00000009663
Gene Symbol: PTGS2
3 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSJJAG00000016996
Gene Symbol: PSMA1
3 Cross references
254 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSJJAG00000001749
Gene Symbol: PSMA3
2 Cross references
193 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSJJAG00000012469
Gene Symbol: PSMA5
3 Cross references
209 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSJJAG00000008311
Gene Symbol: PSMA7
2 Cross references
148 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSJJAG00000022332
Gene Symbol: PSMA8
3 Cross references
197 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSJJAG00000019394
Gene Symbol: PSMB1
3 Cross references
216 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSJJAG00000022755
Gene Symbol: PSMB10
3 Cross references
171 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSJJAG00000015159
Gene Symbol: PSMB2
2 Cross references
218 Possible Orthologues:

Proteasome 20s Subunit Beta 3

Ensembl ID : ENSJJAG00000023648
Gene Symbol: PSMB3
2 Cross references
227 Possible Orthologues:

Proteasome 20s Subunit Beta 4

Ensembl ID : ENSJJAG00000012721
Gene Symbol: PSMB4
3 Cross references
213 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).